Discovery of common and rare genetic risk variants for colorectal cancer
2018 · Nature Genetics · 596 citations
https://doi.org/10.1038/s41588-018-0286-6
R
Robin Myte
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.8K
Citations
21
h-index
27
i10-index
Robin Myte is an academic researcher from AstraZeneca (Finland). The author has contributed to research in topics: Folate and B Vitamins Research & Colorectal Cancer Screening and Detection & Cancer, Lipids, and Metabolism. The author has an h-index of 21, co-authored 45 publications.
ORCID: 0000-0002-2974-2003Papers by this author
worksUntangling the role of one-carbon metabolism in colorectal cancer risk: a comprehensive Bayesian network analysis
2017 · Scientific Reports · 38 citations
https://doi.org/10.1038/srep43434
A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
2021 · Scientific Reports · 29 citations
https://doi.org/10.1038/s41598-021-83968-6
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
2020 · Scientific Reports · 20 citations
https://doi.org/10.1038/s41598-020-62129-1
Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff
2018 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-018-20794-3
Additional file 1 of Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers
2020 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11635023
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat